Ceribell Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 300

Employees

  • Stock Symbol
  • CBLL

Stock Symbol

  • Share Price
  • $26.15
  • (As of Friday Closing)

Ceribell General Information

Description

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Contact Information

Formerly Known As
Brain Stethoscope
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 360 North Pastoria Avenue
  • Sunnyvale, CA 94085
  • United States
+1 (800)
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Stock Exchange
NAS
Corporate Office
  • 360 North Pastoria Avenue
  • Sunnyvale, CA 94085
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ceribell Stock Performance

As of 13-Nov-2026, Ceribell’s stock price is $26.15. Its current market cap is $1.02B with 38.8M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$26.15 $26.35 $12.40 - $28.89 $1.02B 38.8M 442K -$1.95

Ceribell Financials Summary

As of 30-Sep-2026, Ceribell has a trailing 12-month revenue of $109M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 828,729 666,310 1,082,558
Revenue 108,717 89,063 65,444 45,225
EBITDA (71,259) (50,181) (37,322) (26,508)
Net Income (73,884) (53,412) (40,455) (29,464)
Total Assets 156,370 195,803 225,412 58,922
Total Debt 21,650 22,276 21,960 14,204
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ceribell Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ceribell‘s full profile, request access.

Request a free trial

Ceribell Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Ceribell‘s full profile, request access.

Request a free trial

Ceribell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serio
Diagnostic Equipment
Sunnyvale, CA
300 As of 2026

Raleigh, NC
 

Carlsbad, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ceribell Competitors (11)

One of Ceribell’s 11 competitors is Zeto (Monitoring Equipment), a Venture Capital-Backed company based in Raleigh, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zeto (Monitoring Equipment) Venture Capital-Backed Raleigh, NC
Advanced Brain Monitoring Angel-Backed Carlsbad, CA
VirtuOx Corporate Backed or Acquired Coral Springs, FL
NeuroVigil Venture Capital-Backed Mountain View, CA
BrainScope Venture Capital-Backed Rockville, MD
You’re viewing 5 of 11 competitors. Get the full list »

Ceribell Patents

Ceribell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025251844-A1 Systems and methods for seizure detection Pending 02-Apr-2024
US-20250302369-A1 Systems and methods for seizure detection Pending 02-Apr-2024
WO-2025212808-A1 Systems and methods for seizure detection Pending 02-Apr-2024
AU-2024288753-A1 Methods and systems for multi-class classification of seizure Pending 12-Jul-2023
EP-4742975-A2 Methods and systems for multi-class classification of seizure Pending 12-Jul-2023 A61B5/4094
To view Ceribell’s complete patent history, request access »

Ceribell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ceribell Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ceribell‘s full profile, request access.

Request a free trial

Ceribell ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Ceribell’s complete esg history, request access »

Ceribell FAQs

  • When was Ceribell founded?

    Ceribell was founded in 2014.

  • Where is Ceribell headquartered?

    Ceribell is headquartered in Sunnyvale, CA.

  • What is the size of Ceribell?

    Ceribell has 300 total employees.

  • What industry is Ceribell in?

    Ceribell’s primary industry is Diagnostic Equipment.

  • Is Ceribell a private or public company?

    Ceribell is a Public company.

  • What is Ceribell’s stock symbol?

    The ticker symbol for Ceribell is CBLL.

  • What is the current stock price of Ceribell?

    As of 13-Nov-2026 the stock price of Ceribell is $26.15.

  • What is the current market cap of Ceribell?

    The current market capitalization of Ceribell is $1.02B.

  • What is Ceribell’s current revenue?

    The trailing twelve month revenue for Ceribell is $109M.

  • Who are Ceribell’s competitors?

    Zeto (Monitoring Equipment), Advanced Brain Monitoring, VirtuOx, NeuroVigil, and BrainScope are some of the 11 competitors of Ceribell.

  • What is Ceribell’s annual earnings per share (EPS)?

    Ceribell’s EPS for 12 months was -$1.95.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process